Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

Fabio Salvatore Macaluso Mauro GrovaFilippo MocciaroRoberto Di MitriAntonino Carlo PriviteraMaria Emanuela DistefanoAlessandro VitelloSalvatore CamilleriConcetta FerracaneDario PluchinoNunzio BelluardoEmiliano GiangrecoWalter FriesAnna ViolaMaria CappelloLivia D'AmatoCarmelo BertolamiMarco VentimigliaSara RennaAngelo CasàElvira D'AntonioSimona De VivoAmbrogio Orlandonull null

Published in: Journal of gastroenterology and hepatology (2023)

Ustekinumab could be a promising option for the treatment of POR of CD.

Keyphrases

patients undergoing
replacement therapy